Cell-Based Therapeutic Products: Potency Assay Development and Application

References

• CBER. Guidance for industry: potency tests for cellular and gene therapy products ( 2011 ). www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm  
   Google Scholar
• Carmen J , BurgerSR , McCamanMet al. . Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development . Regen. Med.7 , 85 – 100 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rayment EA , WilliamsDJ . Mind the gap: challenges in characterizing and quantifying cell and tissue based therapies for clinical translation . Stem Cells28 , 996 – 1004 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Basu J , LudlowJW . Platform technologies for tubular organ regeneration . Trends Biotechnol.28 , 526 – 533 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Basu J , LudlowJW . Tissue engineering of tubular and solid organs: an industry perspective . In: Advances in Regenerative Medicine.Wislet-Gendebien , S (Ed). Intech Open , Hampshire, UK , 235–260 ( 2011 ). 
   Google Scholar
• Bravery CA , CarmenJ , FongTet al. . Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry . Cytotherapy15 , 9 – 19 ( 2013 ). 
   PubMed Web of Science ®Google Scholar
• Guthrie K , BruceA , SanghaN , RiveraE , BasuJ . Potency evaluation of tissue engineered and regenerative medicine products . Trends Biotechnol.31 , 505 – 514 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• CBER . Guidance for industry, minimally manipulated, unrelated allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution for specified indications(2009) .
   Google Scholar
• Hall KM , HarperH , RichIN . Hematopoietic stem cell potency for cellular therapeutic transplantation. In: Advances in Hematopoietic Stem Cell Research.Intech Open, Hampshire, UK ( 2012 ).
   Google Scholar
• Gavin DK . Cellular, Tissue and Gene Therapies Advisory Committee . www.fda.gov/ohrms/dockets/ac/cber06.html#CellularTissueGeneTherapies  
   Google Scholar
• Caplan AI , CorreaD . The MSC: an injury drugstore . Cell Stem Cell9 , 11 – 15 ( 2011 ). 
   PubMed Web of Science ®Google Scholar
• Jiao J , MilwidJM , YarmushML , ParekkadanB . A mesenchymal stem cell potency assay . Methods Mol. Biol.677 , 221 – 231 ( 2011 ).
   PubMedGoogle Scholar
• Guimaraes-Souza NK , YamalayevaLM , AboushwarebT , AtalaA , YooJJ . In vitro reconstitution of human kidney structures for renal cell therapy . Nephrol. Dial. Transplant.27 , 3082 – 3090 ( 2012 ). 
   PubMed Web of Science ®Google Scholar
• Genheimer CW , IlaganRM , SpencerTet al. . Molecular characterization of the regenerative response induced by intra-renal transplantation of selected renal cells in a rodent model of chronic kidney disease . Cells Tissues Organs196 , 374 – 384 ( 2012 ). 
   PubMed Web of Science ®Google Scholar
• Basu J , GenheimerCW , RiveraEAet al. . Functional evaluation of primary renal cell/biomaterial neo-kidney augment prototypes for renal tissue engineering . Cell Transplant.20 , 1771 – 1790 ( 2011 ). 
   PubMed Web of Science ®Google Scholar
• Lehman N , CutroneR , RaberAet al. . Development of a surrogate angiogenic potency assay for clinical grade stem cell production . Cytotherapy14 , 994 – 1004 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Medicetty S , WiktorD , LehmanNet al. . Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction . Cell Transplant.21 , 1109 – 1120 ( 2012 ). 
   PubMed Web of Science ®Google Scholar
• Hall KM , HarperH , RichIN . Hematopoietic stem cell potency for cellular therapeutic transplantation . http://cdn.intechopen.com/pdfs-wm/27000.pdf  
   Google Scholar
• Kretlow JD , JinYQ , LiuWet al. . Donor age and cell passage affects differentiation potential of murine bone-marrow derived stem cells . BMC Cell Biol.9 , 60 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Noga SJ , SeberA , DavisJMet al. . CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment . J. Hematother.7 , 151 – 157 ( 1998 ).
   PubMedGoogle Scholar
• Basu J , LudlowJW . Developmental engineering the kidney: leveraging principles of morphogenesis for renal regeneration . Birth Defects Res. C Embryo Today96 , 30 – 38 ( 2011 ). 
   Google Scholar
• Camussi G , DeregibusMC , BrunoS , CantaluppiV , BianconeL . Exosomes/micro-vesicles as a mechanism of cell–cell communication . Kidney Int.78 , 838 – 848 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ilagan RM , GuthrieKI , CoxBRet al. . Secreted factors from bioactive kidney cells attenuate NF-κB signaling pathways: implications for a paracrine mechanism of immune regulation and regenerative outcomes . TERMIS-NA . www.tengion.com/pdfs/Ilagan-2010-TERMIS-poster-FINAL.pdf . 
   Google Scholar
• Millipore . Live Cell RNA Detection SmartFlare™ RNA Detection Probes ( 2014 ). www.millipore.com/publications.nsf/a73664f9f981af8c852569b9005b4eee/81545bda4a05766a85257a950049b504/$FILE/PB4438EN00_EM.pdf  
   Google Scholar
• Ratliff BB , SinghN , YasudaKet al. . Mesenchymal stem cells, used as bait, disclose tissue binding sites: a tool in the search for the niche?Am. J. Pathol.177 , 873 – 883 ( 2010 ). 
   PubMed Web of Science ®Google Scholar
• Zeisberg M , MaeshimaY , MostermanB , KalluriR . Extra-cellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells . Am. J. Pathol.160 , 2001 – 2008 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Kelley R , WerdinES , BruceATet al. . A tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in a rodent model of chronic kidney disease . Am. J. Physiol. Renal Physiol.299 , F1026 – F1039 ( 2010 ). 
   PubMed Web of Science ®Google Scholar
• Dudas PL , ArgentieriRL , FarrellFX . BMP7 fails to attenuate TGFbeta1 induced epithelial-mesenchymal transition in human proximal tubule epithelial cells . Nephrol. Dial. Transplant.24 , 1406 – 1416 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• FDA issues draft guidance on biosimilar product development. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm291232.htm  
   Google Scholar
• Sagrinati C , RonconiE , LazzeriE , LasagniL , RomagnaniP . Stem cell approaches for kidney repair: choosing the right cells . Trends Mol. Med.14 , 277 – 85 ( 2008 ).
   PubMed Web of Science ®Google Scholar